351 related articles for article (PubMed ID: 35814833)
1. Tumor metabolic reprogramming in lung cancer progression.
Li X; Liu M; Liu H; Chen J
Oncol Lett; 2022 Aug; 24(2):287. PubMed ID: 35814833
[TBL] [Abstract][Full Text] [Related]
2. Research progress of hyperthermia in tumor therapy by influencing metabolic reprogramming of tumor cells.
Yang Y; Huangfu L; Li H; Yang D
Int J Hyperthermia; 2023; 40(1):2270654. PubMed ID: 37871910
[TBL] [Abstract][Full Text] [Related]
3. The role of metabolic reprogramming in pancreatic cancer chemoresistance.
Liu C; Li C; Liu Y
Front Pharmacol; 2022; 13():1108776. PubMed ID: 36699061
[TBL] [Abstract][Full Text] [Related]
4. Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification.
Talapatra J; Reddy MM
Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046804
[TBL] [Abstract][Full Text] [Related]
5. Amino acid metabolic reprogramming in tumor metastatic colonization.
Wang Z; Wu X; Chen HN; Wang K
Front Oncol; 2023; 13():1123192. PubMed ID: 36998464
[TBL] [Abstract][Full Text] [Related]
6. Cancer metabolism and intervention therapy.
Zhao H; Li Y
Mol Biomed; 2021 Feb; 2(1):5. PubMed ID: 35006438
[TBL] [Abstract][Full Text] [Related]
7. Intracellular metabolic reprogramming mediated by micro-RNAs in differentiating and proliferating cells under non-diseased conditions.
Singh V
Mol Biol Rep; 2021 Dec; 48(12):8123-8140. PubMed ID: 34643930
[TBL] [Abstract][Full Text] [Related]
8. Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming.
Li Z; Sun C; Qin Z
Theranostics; 2021; 11(17):8322-8336. PubMed ID: 34373744
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide and tumor metabolic reprogramming.
López-Sánchez LM; Aranda E; Rodríguez-Ariza A
Biochem Pharmacol; 2020 Jun; 176():113769. PubMed ID: 31862448
[TBL] [Abstract][Full Text] [Related]
10. Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more.
Hao X; Ren Y; Feng M; Wang Q; Wang Y
Biomed Pharmacother; 2021 Sep; 141():111798. PubMed ID: 34120068
[TBL] [Abstract][Full Text] [Related]
11. Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer.
Shum HCE; Wu K; Vadgama J; Wu Y
J Pers Med; 2023 Jan; 13(1):. PubMed ID: 36675817
[TBL] [Abstract][Full Text] [Related]
12. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Reprogramming of Thyroid Cancer Cells and Crosstalk in Their Microenvironment.
Bao L; Xu T; Lu X; Huang P; Pan Z; Ge M
Front Oncol; 2021; 11():773028. PubMed ID: 34926283
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis.
Ohshima K; Morii E
Metabolites; 2021 Jan; 11(1):. PubMed ID: 33401771
[TBL] [Abstract][Full Text] [Related]
15. Metabolic reprogramming in cancer: Mechanisms and therapeutics.
Nong S; Han X; Xiang Y; Qian Y; Wei Y; Zhang T; Tian K; Shen K; Yang J; Ma X
MedComm (2020); 2023 Apr; 4(2):e218. PubMed ID: 36994237
[TBL] [Abstract][Full Text] [Related]
16. Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment.
Sasidharan Nair V; Saleh R; Toor SM; Cyprian FS; Elkord E
Cancer Immunol Immunother; 2021 Aug; 70(8):2103-2121. PubMed ID: 33532902
[TBL] [Abstract][Full Text] [Related]
17. Targeting metabolic reprogramming in chronic lymphocytic leukemia.
Nie Y; Yun X; Zhang Y; Wang X
Exp Hematol Oncol; 2022 Jun; 11(1):39. PubMed ID: 35761419
[TBL] [Abstract][Full Text] [Related]
18. Emerging roles of non-coding RNAs in the metabolic reprogramming of tumor-associated macrophages.
Li J; Lu Z; Zhang Y; Xia L; Su Z
Immunol Lett; 2021 Apr; 232():27-34. PubMed ID: 33577913
[TBL] [Abstract][Full Text] [Related]
19. Metabolic reprogramming in the pathogenesis of chronic lung diseases, including BPD, COPD, and pulmonary fibrosis.
Zhao H; Dennery PA; Yao H
Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L544-L554. PubMed ID: 29351437
[TBL] [Abstract][Full Text] [Related]
20. Lipid metabolism in cancer progression and therapeutic strategies.
Fu Y; Zou T; Shen X; Nelson PJ; Li J; Wu C; Yang J; Zheng Y; Bruns C; Zhao Y; Qin L; Dong Q
MedComm (2020); 2021 Mar; 2(1):27-59. PubMed ID: 34766135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
